Bristol-Myers introduced BLENOXANE (bleomycin sulfate) for squamous cell cancers, head and neck cancers, and non-Hodgkins lymphomas

In 1973, Bristol-Myers introduced several early medicines, beginning with BLENOXANE (bleomycin sulfate) for squamous cell cancers, head and neck cancers, and non-Hodgkins lymphomas.

Tags:

Source: Bristol-Myers Squibb Company
Credit:

Visit News/History Source
LifeScienceHistory.com offers three advertising package options. Each package lnclude at least two digital images for multiple page placements and maximum exposure! Rates range from just $300 to $500 per month.